Anand Rathi Wealth Limited has informed the Exchange regarding Outcome of the Board meeting held on Monday, January 12, 2026 as under: 1. Unaudited Financial Results (Standalone & Consolidated) of the Company for the third quarter and nine months ended 31st December, 2025;2. Appointment of Mr. Adesh Kumar Gupta (DIN:00020403) as an Additional Director in the category of Non-Executive Independent Director;3. Appointment of Mr. Debasish Panda (DIN: 06479085) as an Additional Director in the category of Non-Executive Independent Director;4. Appointment of Ms. Deena Asit Mehta (DIN: 00168992) as an Additional Director in the category of Non-Executive Independent Director;5. Re-appointment of Mr. Rakesh Rawal (DIN: 02839168) as Whole-time Director and CEO of the Company for a period of 3 years from 1st April 2026 to 31st March, 2029;6. Shifting of Registered Office of the Company;7. The Nomination and Remuneration committee has granted 12,45,309 (Twelve Lakhs Forty Five Thousand Three Hundred and Nine) Employee Stock options to the eligible Employee(s)
ANANDRATHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anand Rathi Wealth reported strong Q3 FY26 results with consolidated revenue from operations of ₹28,962 lakhs, up about 22% year-on-year, and net profit of ₹10,019 lakhs, up roughly 30% year-on-year. For the nine months ended December 2025, consolidated net profit rose to ₹29,399 lakhs from ₹22,705 lakhs a year earlier. Standalone net profit for the quarter was ₹9,981 lakhs versus ₹7,570 lakhs last year. The board also appointed three new independent directors including former IRDAI chairman Debasish Panda and former Grasim CFO Adesh Kumar Gupta, re-appointed CEO Rakesh Rawal for three years from April 2026, granted 12.45 lakh ESOPs at ₹5 each, and approved shifting the registered office to Lower Parel, Mumbai.
Robust profit growth and high-profile independent director additions should be viewed positively by shareholders, signaling both operational strength and strengthened governance. The ESOP grant at face value and the re-appointment of the existing CEO provide continuity, while the sale of the Freedom Wealth subsidiary and small UK subsidiary setup reflect portfolio reshaping with no material earnings impact.